Fifth Lane Capital’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Fifth Lane Capital’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$30K	–	210
2023 Q4	$30K	Hold	100,000	–	–	0.04%	43
2023 Q3	$30K	Buy	100,000 +50,000	+100%	+$13.2K	0.01%	140
2023 Q2	$8.5K	Hold	50,000	–	–	﹤0.01%	155
2023 Q1	$7.01K	Hold	50,000	–	–	﹤0.01%	127
2022 Q4	$2.5K	Hold	50,000	–	–	﹤0.01%	132
2022 Q3	$2K	Buy	50,000 +25,000	+100%	+$2.76K	﹤0.01%	197
2022 Q2	$3K	Hold	25,000	–	–	﹤0.01%	311
2022 Q1	$4K	Hold	25,000	–	–	﹤0.01%	312
2021 Q4	$8K	Buy	+25,000	New	+$7.91K	﹤0.01%	285

Fifth Lane Capital's DMAQR Position: Q1 2024 in Review

Fifth Lane Capital sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 100,000 shares — an estimated $30K sold.

Fifth Lane Capital first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $30K in Q4 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Fifth Lane Capital reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Fifth Lane Capital sold 100,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $30K.
Fifth Lane Capital first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Fifth Lane Capital's Deep Medicine Acquisition Corp. Rights position peaked at $30K in Q4 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Fifth Lane Capital's 13F filing for Q1 2024, filed 2 May 2024.